LPL Financial
CBPO

LPL Financial’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

LPL Financial’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,263
Closed -$482K – 2993
2017
Q2 		$482K Sell
4,263
-3,065
-42% -$343K ﹤0.01% 1911
2017
Q1 		$735K Buy
7,328
+516
+8% +$55.1K 0.01% 1486
2016
Q4 		$737K Buy
6,812
+1,958
+40% +$229K 0.01% 1421
2016
Q3 		$599K Buy
+4,854
New +$573K 0.01% 1560
2016
Q1 		– Sell
-1,600
Closed -$211K – 3261
2015
Q4 		$211K Buy
+1,600
New +$185K ﹤0.01% 2788

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

LPL Financial's CBPO Position: Q3 2017 in Review

LPL Financial sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 4,263 shares — an estimated $482K sold.

LPL Financial first reported a position in CBPO in Q4 2015 and held it in 5 quarters. The position peaked at $737K in Q4 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • LPL Financial reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • LPL Financial sold 4,263 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $482K.
  • LPL Financial first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 5 quarters.
  • LPL Financial's China Biologic Products Holdings, Inc. position peaked at $737K in Q4 2016.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on LPL Financial's 13F filing for Q3 2017, filed 14 Nov 2017.